These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2510657)

  • 21. Pharmacokinetics and pharmacodynamics of the ETA-selective endothelin receptor antagonist SPP301 in healthy human subjects.
    Dieterle W; Mann J; Kutz K
    J Clin Pharmacol; 2004 Jan; 44(1):59-66. PubMed ID: 14681342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cadralazine on systemic blood pressure, renal function and plasma renin activity in anesthetized dogs.
    Yukimura T; Miura K; Tanaka M; Higashio T; Sakaguchi S; Kuroda K; Yamamoto K
    Arzneimittelforschung; 1988 Jan; 38(1):25-8. PubMed ID: 3284531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic effects of cadralazine or chlorthalidone in verapamil-treated elderly hypertensives.
    Antonicelli R; Savonitto S; Tomassini PF; Gambini C; Sardina M; Paciaroni E
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):198-203. PubMed ID: 8032580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure and hemodynamics in postmenopausal women during estradiol-17 beta substitution.
    Luotola H
    Ann Clin Res; 1983; 15 Suppl 38():1-121. PubMed ID: 6367617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
    Baldoli E; Bianchi G; Corsico N; Di Francesco GF
    Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women.
    Peck RW; Seaber EJ; Dixon RM; Layton GR; Weatherley BC; Jackson SH; Rolan PE; Posner J
    Clin Pharmacol Ther; 1998 Mar; 63(3):342-53. PubMed ID: 9542478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemorheologic effects of vasodilation in essential hypertension.
    Wysocki M; Andersson OK; Persson B; Bagge U; Braide M
    Angiology; 1996 Sep; 47(9):869-78. PubMed ID: 8810653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular haemodynamic response to repeated mental stress in normotensive subjects at genetic risk of hypertension: evidence of enhanced reactivity, blunted adaptation, and delayed recovery.
    Schneider GM; Jacobs DW; Gevirtz RN; O'Connor DT
    J Hum Hypertens; 2003 Dec; 17(12):829-40. PubMed ID: 14704727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological studies on cadralazine: a new antihypertensive vasodilator drug.
    Semeraro C; Dorigotti L; Banfi S; Carpi C
    J Cardiovasc Pharmacol; 1981; 3(3):455-67. PubMed ID: 6168827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cadralazine, a new vasodilator, in addition to a beta-blocker for long-term treatment of hypertension.
    Salvadeo A; Villa G; Segagni S; Piazza V; Picardi L; Romano M; Parini J
    Arzneimittelforschung; 1985; 35(3):623-5. PubMed ID: 2859865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of acetylator phenotype on the pharmacokinetics of a new vasodilator antihypertensive, endralazine.
    Reece PA; Cozamanis I; Zacest R
    Eur J Clin Pharmacol; 1982; 23(6):523-7. PubMed ID: 7160421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
    Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Human pharmacokinetic study of nerisopam and its n-acetyl metabolite].
    Róna K; Ary K; Renczes G; Gachályi B; Grézal G; Drabant S; Csörgö M; Klebovich I
    Acta Pharm Hung; 1997; 67(2-3):65-71. PubMed ID: 9289938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of complement components C3 and C4 by cadralazine and its active metabolite.
    Andersson M; Hanson A; Englund G; Dahlbäck B
    Eur J Clin Pharmacol; 1991; 40(3):261-5. PubMed ID: 2060562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human pharmacokinetics of cadralazine: a new vasodilator.
    Hauffe SA; Dubois JP; Imhof PR
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):217-23. PubMed ID: 4085523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of cadralazine in a large group of hypertensive patients chronically treated with cadralazine: advantage over a conventional study in a small group of patients.
    Lecaillon JB; Dubois JP; Darragon T; Motolese M; Racine A; Ducret F; Grouberman D; Cordonnier D; Chanard J; Glorioso M
    Ther Drug Monit; 1991 Mar; 13(2):103-8. PubMed ID: 2053115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of ISF-2405, an active metabolite of cadralazine, in plasma and tissues by radioimmunoassay.
    Terauchi Y; Watari S; Ishikawa S; Nakao M; Negoro T; Kagemoto A; Sekine Y; Hashimoto M
    J Pharmacobiodyn; 1987 Dec; 10(12):758-66. PubMed ID: 3451960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of an intact endothelium in the vascular action of cadralazine and ISF2405.
    Buccellati C; Dorigotti L; Lombroso M; Folco G
    Pharmacol Res; 1989; 21 Suppl 1():85-6. PubMed ID: 2633196
    [No Abstract]   [Full Text] [Related]  

  • 39. [Influence of acetylation phenotype on the pharmacokinetics and pharmacodynamics data of cadralazine in normotensive subjects].
    Brunel P; Lecaillon JB; Imhof P; Menard J
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1257-60. PubMed ID: 2510657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of acetylator status on the haemodynamic effects and pharmacokinetics of cadralazine in healthy subjects.
    Brunel P; Lecaillon JB; Guyene TT; Imhof P; Ménard J
    Br J Clin Pharmacol; 1990 May; 29(5):503-9. PubMed ID: 2190629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.